Prothena Corp. (PRTA) Misses Q2 EPS by 7c

Prothena Corp. (NASDAQ: PRTA) reported Q2 EPS of ($1.03), $0.07 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $4.02 million versus the consensus estimate of $5.09 million.

For earnings history and earnings-related data on Prothena Corp. (PRTA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c